Objectives: Results and complications of surgical versus transcatheter treatment of atrial
septal defect in the current era are compared. Methods: All consecutive patients with a …

To judge whether an Amplatzer Septal Occluder (ASO) can be used as a safe therapy
instead of surgery for closure of large atrial septal defects> 25 mm in diameter, we report our …

Transcatheter closure of atrial septal defects (ASDs) was performed mainly in children and
adolescents. Information about outcome and complications in adults was limited. From …

BACKGROUND: The Amplatzer Septal Occluder (ASO)(AGA Medical Corp, Golden Valley,
Minn) has gained wide acceptance for transcatheter closure of atrial septal defect (ASD). We …

Our study reports the results of a comparison of closure of atrial septal defect (ASD)
surgically with transcatheter closure using the Amplatzer septal occluder. Patients having an …

Background In adults with atrial septal defect (ASD) and large right-to-left shunt, closure of
the defect is recommended. Percutaneous closure is still rarely used in this population. This …

Device closure of oval fossa atrial scptal defects with the Amplatzer Septal Occluder was
performed in 26 patients ranging in age from 0.89 to 60.44 years. In eight additional patients …

Objective: To compare effectiveness, complications, and cost of Amplatzer with surgical
atrial septal defect (ASD) closure. Design: Prospective study. Setting: Tertiary cardiac …

Percutaneous device occlusion of secundum atrial septal defects (ASDs) is becoming an
accepted alternative to surgical closure. This method allows us to evaluate patients with …

Abstract Between June 1999 and September 2002, 45 patients (age, 34±13 years; mean
shunt ratio, 2.6±0.6) underwent transcatheter atrial septal defect (ASD) closure at our …